AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Akso Health Group Reports Delayed Annual Filing, CEO Signature Ensures Compliance.
ByAinvest
Saturday, Aug 2, 2025 5:22 pm ET1min read
Akso Health Group has delayed its annual report filing due to a need for additional time to review and finalize financial statements. The company expects to file the report within 15 calendar days of the original due date and there are no anticipated significant changes in financial results from the previous fiscal year.
Akso Health Group ADR (AHG) has announced a delay in filing its annual report, citing the need for additional time to review and finalize financial statements. The company expects to submit the report within 15 calendar days of the original due date. There are no anticipated significant changes in financial results from the previous fiscal year [1].The delay comes as the company continues to navigate its operational and financial complexities. Akso Health Group is a global provider of advanced robotic devices used in physical rehabilitation, incorporating visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training. The company has been actively working with its auditors and advisors to ensure compliance with regulatory requirements [2].
Despite the delay, the company remains focused on its strategic initiatives. Akso Health Group has seen growing potential in its personal health segment, specifically the Ekso Indigo personal exoskeleton, a robotic mobility device. Personal health product revenues grew more than 50% in the first six months of 2025, with expectations of reaching 25% of total company revenue this year. The company has also partnered with various healthcare enterprises to navigate market access complexities and has launched a virtual platform for continuing education courses for physical therapists [3].
The delay in filing the annual report does not have an immediate impact on the company's listing or trading on Nasdaq. Investors are advised to closely monitor the company's progress and the expected filing date for further updates.
References:
[1] https://www.barchart.com/stocks/quotes/AHG/opinion/100-200-Day-MA-Crossover/strategy-charts
[2] https://www.stocktitan.net/news/DHAI/dih-holding-us-inc-receives-notification-of-deficiency-from-nasdaq-mrc0exf2m1tg.html
[3] https://www.pressdemocrat.com/article/north-bay/ekso-bionics-q2-2025/?ref=home-business
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments

No comments yet